Rani Therapeutics Hldgs Bolsa (NASDAQ: RANI)

Rani Therapeutics Hldgs (NASDAQ:RANI) Bolsa

RANI THERAPEUTICS HOLDINGS-A

Rani Therapeutics Hldgs

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

APPS

AVGR

BBAI

COHR

DGLY

FORM

MBRX

MTRX

PTIX

RANI

RXRX

SBET

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SLXN

SWKS

Coherent sorprende con sus resultados trimestrales y dispara sus acciones un 15,5%. ¿Qué otras empresas se mueven en el premercado de EE.UU.?

Acciones de Coherent (COHR) se disparan un 15%; 20 acciones que se mueven en el premercado de EE.UU.

Analyst Color

Earnings

Equities

Futures

Economics

Analyst Ratings

AMZN

FTNT

NVDA

RBLX

SANG

Las acciones de EE.UU. suben mientras los inversores analizan los aranceles, resultados financieros y expectativas de la Fed.

Los futuros de Wall Street suben: ¿Cómo impactarán los aranceles y las ganancias empresariales?

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Holdings Inc

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Lexicon Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXRX#NASDAQ">LXRX</a>) with a Buy and maintains $4 price target.

Price Target

Reiteration

LXRX

HC Wainwright & Co. Reiterates Buy on Lexicon Pharmaceuticals, Maintains $4 Price Target

The Global Advisory Board brings together renowned business leaders to advise, guide and champion Endava's leadership position within the technology industry
Endava (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAVA#NYSE">DAVA</a>), a leading business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announces the formation of its global advisory board.
Following 18 months of embedding AI across its own operations and collaborating with strategic partners and clients to drive AI-powered business outcomes, Endava has formed a prestigious group of advisors and ambassadors to help Endava in aiding the world's leading companies harness the power of AI to achieve transformative results.

DAVA

Endava Announces Formation Of Its Global Advisory Board

IXHL

Incannex Appoints Sleep Medicine Expert Douglas Kirsch To Advisory Board As IHL-42X OSA Program Nears Phase 2 Data Readout

OSTX

OS Therapies Receives FDA Feedback On Accelerated Approval Pathway For OST-HER2 In Pediatric Lung Metastatic Osteosarcoma; Seeks Breakthrough Therapy Designation

NKTR

Nektar's Rezpegaldesleukin Meets Primary And Key Secondary Endpoints In Phase 2b REZOLVE-AD Trial For Atopic Dermatitis, Showing Efficacy And Safety

Loop Capital analyst Anthony Chukumba downgrades Ollie's Bargain Outlet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) from Buy to Hold and maintains the price target from $130 to $130.

Downgrades

OLLI

Loop Capital Downgrades Ollie's Bargain Outlet to Hold, Maintains Price Target to $130

XCHG Limited's XCharge NA Deploys Two Dual-Dispenser GridLink Chargers At Newly Launched EV Charging Depot In Riverside, California, Developed And Operated By Gateway Fleets

AeroVironment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) will release earnings results for the fourth quarter, after the <a href="https://www.benzinga.com/quote/AVAV/earnings">closing bell on Tuesday, June 24.</a>
Analysts expect the Arlington, Virginia-based company to report quarterly earnings at $1.42 per share on revenue of $242.69 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On June 18, AeroVironment and UAS Denmark announced a strategic partnership to advance allied UAS capabilities in Europe.
AeroVironment shares gained 0.8% to close at $191.23 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/avav/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Baird analyst Peter Arment maintained an Outperform rating and raised the price target from $146 to $210 on June 6, 2025. This analyst has an accuracy rate of 84%.</li>
<li>RBC Capital analyst Ken Herbert reinstated an Outperform rating with a price target of $190 on May 12, 2025. This analyst has an accuracy rate of 74%.</li>
<li>BTIG analyst Andre Madrid reiterated a Buy rating with a price target of $245 on Sept. 17, 2024. This analyst has an accuracy rate of 73%.</li>
<li>Raymond James analyst Brian Gesuale downgraded the stock from Outperform to Market Perform on Sept. 17, 2024. This analyst has an accuracy rate of 74%.</li>
<li>Alembic Global analyst Peter Skibitski upgraded the stock from Neutral to Overweight with a price target of $216 on Aug. 28, 2024. This analyst has an accuracy rate of 73%</li>
</ul>
Considering buying AVAV stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/avav/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="574" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24030520/image-346-1024x574.png" alt="" class="wp-image-959192" style="width:674px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24030520/image-346-1024x574.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24030520/image-346-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24030520/image-346-768x431.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24030520/image-346.png 1145w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/06/46050117/wall-streets-most-accurate-analysts-give-their-take-on-3-tech-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Tech Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

AVAV

Top Wall Street Forecasters Revamp AeroVironment Expectations Ahead Of Q4 Earnings

Acacia Research Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) ("Acacia" or the "Company"), which acquires and operates businesses across the industrial, energy and technology sectors, today announced the appointment of Michael Zambito as Chief Financial Officer, effective June 24, 2025. Kirsten Hoover, Acacia's current Interim Chief Financial Officer, will continue to serve as Acacia's Controller and remains a key member of Acacia's finance team.
Prior to joining Acacia, Mr. Zambito spent the past 30 years at Ernst &amp; Young, a multinational professional services firm, and a global leader in assurance, tax, transactions, and consulting services. Most recently, he spent over 23 years, including the last 17 as a Partner, in Ernst &amp; Young's EY-Parthenon (formerly Strategy and Transactions) practice, a market-leading strategy, transactions, and corporate finance provider. Prior to this, he spent seven years in Ernst &amp; Young's NY audit practice, as staff through manager. Mr. Zambito received his MBA from Columbia Business School and holds a Bachelor of Science degree in Business Administration with a major in Accounting from the University of Richmond.

Management

ACTG

Acacia Appoints EY Veteran Michael Zambito as CFO, Former Interim CFO Kirsten Hoover Stays On as Controller

Macro Economic Events

Politics

Global

General

iShares MSCI Israel Capped Investable Market Index Fund

President Trump Posts On Truth Social: 'IRAN WILL NEVER REBUILD THEIR NUCLEAR FACILITIES!'

OPRX

OptimizeRx Appoints CEO Steve Silvestro To Board Of Directors To Strengthen Leadership And Advance Strategic Growth Plans

President Trump On Truth Social Posts: 'ISRAEL is not going to attack Iran. All planes will turn around and head home, while doing a friendly "Plane Wave" to Iran. Nobody will be hurt, the Ceasefire is in effect! Thank you for your attention to this matter! DONALD J. TRUMP, PRESIDENT OF THE UNITED STATES'

WhatsApp&nbsp;has emerged as a key arena for AI chatbot competition, reportedly posing a potential challenge to&nbsp;Meta Platforms Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) AI dominance.
What Happened: WhatsApp, with over 3 billion global users, has become a prime platform for various AI chatbots, including those from OpenAI and Perplexity, alongside Meta&#8217;s own assistant, <a href="https://www.businessinsider.com/meta-ai-competition-whatsapp-chatbot-battleground-2025-6">reported</a> Business Insider. This intense competition could potentially hinder Meta AI&#8217;s goal of becoming the default choice for its billions of users.
Notably, in the April earnings call, Meta&#8217;s CEO, Mark Zuckerberg, revealed that WhatsApp is &#8220;the&nbsp;largest surface that people use&nbsp;Meta AI on.&#8221;
WhatsApp, a primary battleground for consumer AI, is witnessing a surge in rival chatbots vying for user attention. Despite Meta AI being integrated into WhatsApp, the app&#8217;s strong usage continues.
OpenAI, which brought ChatGPT to WhatsApp last year, is working to make AI more widely accessible. Meanwhile, Perplexity&#8217;s chatbot, launched on WhatsApp this spring, experienced such overwhelming demand at launch that it briefly crashed.
These competing chatbots utilize the WhatsApp Business Platform, allowing them to reach WhatsApp&#8217;s vast global audience without requiring Meta&#8217;s direct approval. This is particularly beneficial in emerging markets&nbsp;such as India and Brazil, where&nbsp;WhatsApp is a primary communication tool.
Meta did not immediately respond to <a href="http://pro.benzinga.com">Benzinga&#8217;s</a> request for comment.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/23/06/33000234/california-democrat-ro-khanna-questions-feds-2-inflation-target-why-is-it-sacrosanct-as-opposed-to-s" target="_blank" rel="noreferrer noopener">Ro Khanna Wants To Know Why Fed's 2% Inflation Target Is &#8216;Sacrosanct&#8217; &#8211; Benzinga</a>
Why It Matters: The rise of AI chatbots on WhatsApp comes at a time when Meta is facing challenges. Just a day before this report,&nbsp;WhatsApp was banned on<a href="https://www.benzinga.com/markets/tech/25/06/46066338/whatsapp-blocked-on-us-house-devices-over-transparency-encryption-concerns-meta-app-deemed-high-risk-while-imessage-facetime-and-teams-get-green-light"> U.S. House</a> devices&nbsp;over transparency and encryption concerns, further complicating Meta&#8217;s position.
However, Meta&#8217;s WhatsApp is not without its potential. An analyst recently estimated that Meta could potentially generate over <a href="https://www.benzinga.com/markets/tech/25/06/45969694/mark-zuckerbergs-meta-could-rake-in-over-10-billion-in-annual-ad-revenue-from-whatsapp-by-2028-says-analyst">$10 billion</a> in annual ad revenue from its&nbsp;WhatsApp messaging service by 2028, indicating that the platform still holds significant value for the company.
Benzinga's Edge Rankings place Meta Platforms in the 85th percentile for momentum and the 28th percentile for value, reflecting its strong performance in both areas. Check the detailed report <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a>.&nbsp;
On a year-to-date basis, Meta stock surged 16.57%, according to data from <a href="http://pro.benzinga.com">Benzinga Pro.</a>
<ul class="wp-block-list">
<li>READ MORE: <a href="https://www.benzinga.com/markets/tech/25/06/46050532/mark-zuckerbergs-maga-pivot-driven-by-elon-musk-envy-image-goals-say-betrayed-meta-insiders-report">Mark Zuckerberg&#8217;s MAGA Pivot Driven By Elon Musk Envy, Image Goals, Say &#8216;Betrayed&#8217; Meta Insiders: Report</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Mark Zuckerberg's AI Dreams Hit WhatsApp Speed Bump As OpenAI, Perplexity Challenge Meta On Its Own Turf: Report

Digital Asset, the developer behind the Canton Network, has raised $135 million in a funding round backed by major Wall Street players <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42047066/goldman-sachs-to-spin-out-digital-assets-platform-amid-blockchain-push">including Goldman Sachs</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) and Citadel Securities, alongside leading crypto investors.
The round, led by DRW Venture Capital and Tradeweb Markets, signals growing institutional confidence in blockchain solutions designed for traditional finance.
The new capital will <a href="https://www.prnewswire.com/news-releases/digital-asset-raises-135-million-to-accelerate-adoption-of-canton-network-302488899.html">accelerate</a> the onboarding of real-world assets onto the Canton Network, which Digital Asset describes as the first public, permissionless Layer-1 blockchain offering configurable privacy for institutional use.
The network already supports a broad range of assets, including bonds, commodities, repos, mortgages, and alternative funds.
Other participants in the round include BNP Paribas, Circle Ventures, The Depository Trust &amp; Clearing Corporation (DTCC), IMC, Liberty City Ventures, Optiver, Paxos, Polychain Capital, QCP, Republic Digital, 7RIDGE and Virtu Financial.
Also Read: <a href="https://www.benzinga.com/markets/tech/25/06/46055372/new-crypto-fund-targets-early-builders-is-this-where-the-next-blockchain-unicorn-starts">New Crypto Fund Targets Early Builders: Is This Where The Next Blockchain Unicorn Starts?</a>
Goldman Sachs' Mathew McDermott said, "Our longstanding relationship with Digital Asset stems from a deep conviction in the strength of their technology, which continues to be foundational to the development and ongoing success of GS DAP."
Don Wilson, CEO of DRW, emphasized the maturity of the market, stating, "We are at the inflection point of being able to use blockchain at scale in traditional markets."
The funding is set to bolster Canton&#8217;s position as a blockchain protocol tailored for regulated institutions, offering privacy controls that have long been a barrier to enterprise blockchain adoption. 
Digital Asset says Canton already has nearly 400 participants within its ecosystem, reflecting momentum among both traditional and decentralized finance players.
Digital Asset CEO Yuval Rooz added, "This funding milestone validates the inevitability of what we envisioned years ago: a privacy-enabled public blockchain designed specifically for institutional adoption."
The Canton Network enables asset synchronization across financial markets with an emphasis on real-time, private, and interoperable settlement, a feature that its backers see as a step toward modernizing financial infrastructure.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46053180/sequans-takes-a-page-from-microstrategy-is-bitcoin-the-new-corporate-treasury-play">Sequans Takes A Page From MicroStrategy: Is Bitcoin The New Corporate Treasury Play?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

What's Driving Goldman Sachs And Citadel Into Crypto? The $135M Digital Asset Funding Round Explained

Macquarie analyst Aditya Suresh upgrades MakeMyTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) from Neutral to Outperform and announces $110 price target.

Upgrades

MMYT

Macquarie Upgrades MakeMyTrip to Outperform, Announces $110 Price Target

Affiliates Of CriticalPoint Acquires Consumer Wearables Brand Pura Vida Bracelets From Vera Bradley For Undisclosed Terms

<ul>
<li>Comprehensive restructuring eliminates the potential issuance of up to 1.5 billion shares of common stock</li>
<li>Plus Therapeutics files a request to withdraw the related resale registration statement with the SEC</li>
</ul>

PSTV

Plus Therapeutics Restructures $15m Equity Financing, Cancels Warrants And Pre-Funded Shares To Simplify Capital Structure

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the utilities sector.
<h3 class="wp-block-heading">The AES Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AES#NYSE">AES</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 6.87%</li>
<li>Argus Research analyst Gary Hovis downgraded the stock from Buy to Hold on May 27, 2025. This analyst has an accuracy rate of 62%.</li>
<li>Jefferies analyst Julien Dumoulin-Smith downgraded the stock from Hold to Underperform and slashed the price target from $10 to $9 on May 20, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On May 1, AES announced it has reaffirmed 2025 guidance and long-term growth rate targets.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest AES <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0624">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0624"><img loading="lazy" decoding="async" width="938" height="838" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24054242/image-351.png" alt="" class="wp-image-959490" style="width:613px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24054242/image-351.png 938w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24054242/image-351-300x268.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24054242/image-351-768x686.png 768w" sizes="(max-width: 938px) 100vw, 938px" /></a></figure>
<h3 class="wp-block-heading">Portland General Electric Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POR#NYSE">POR</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 5.11%</li>
<li>Barclays analyst Nicholas Campanella maintained an Equal-Weight rating and cut the price target from $48 to $45 on April 30, 2025. This analyst has an accuracy rate of 62%.</li>
<li>Wells Fargo analyst Sarah Akers maintained an Equal-Weight and lowered the price target from $46 to $44 on April 28, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On April 25, Portland Gen Electric posted downbeat quarterly results.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest POR <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0624">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0624"><img loading="lazy" decoding="async" width="928" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24054320/image-352.png" alt="" class="wp-image-959491" style="width:625px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24054320/image-352.png 928w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24054320/image-352-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24054320/image-352-768x697.png 768w" sizes="(max-width: 928px) 100vw, 928px" /></a></figure>
<h3 class="wp-block-heading">Avista Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVA#NYSE">AVA</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 5.13%</li>
<li>Jefferies analyst Julien Dumoulin-Smith maintained a Hold rating and lowered the price target from $40 to $39 on Jan. 28, 2025. This analyst has an accuracy rate of 67%.</li>
<li>B of A Securities analyst Ross Fowler reinstated an Underperform rating with a price target of $37 on Sept. 12, 2024. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: On June 9, Avista reached all-party, all issues settlement in Idaho general rate cases.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0624">AVA news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0624"><img loading="lazy" decoding="async" width="923" height="845" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24054357/image-353.png" alt="" class="wp-image-959492" style="width:602px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24054357/image-353.png 923w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24054357/image-353-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24054357/image-353-768x703.png 768w" sizes="(max-width: 923px) 100vw, 923px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46067537/blackberry-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts">BlackBerry Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Photo via Shutterstock

Dividends

Wall Street's Most Accurate Analysts Spotlight On 3 Utilities Stocks With Over 5% Dividend Yields

REGN

Regeneron Launches $200M Donation Matching Program With Good Days To Expand Access To Vision-Saving Treatments In 2025

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Clean Energy Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETY#NASDAQ">CETY</a>)</h3>
<ul class="wp-block-list">
<li>On May 23, Clean Energy Technologies announced it signed a non-binding offer with an European solar and wind development company for approximately $85 million. The company's stock fell around 20% over the past month and has a 52-week low of $0.25.</li>
<li>RSI Value: 29.9</li>
<li>CETY Price Action: Shares of Clean Energy Technologies fell 2.7% to close at $0.25 on Monday.</li>
<li>Edge Stock Ratings: 91.92 Momentum score with Value at 93.51.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/CETY"><img loading="lazy" decoding="async" width="410" height="180" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24045338/image-349.png" alt="" class="wp-image-959378" style="width:346px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24045338/image-349.png 410w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24045338/image-349-300x132.png 300w" sizes="(max-width: 410px) 100vw, 410px" /></a></figure>
<h3 class="wp-block-heading">Black Stone Minerals LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSM#NYSE">BSM</a>)&nbsp;&nbsp;&nbsp;</h3>
<ul class="wp-block-list">
<li>On May 19, Black Stone Minerals announced that it has entered into a development agreement with Revenant Energy with respect to the Partnership&#8217;s expanded Shelby Trough Haynesville and Bossier acreage, primarily located in Angelina, Nacogdoches, and San Augustine counties in Texas. The company's stock fell around 7% over the past five days and <a href="https://www.benzinga.com/quote/BSM">has a 52-week low</a> of $12.80.</li>
<li>RSI Value: 28</li>
<li>BSM Price Action: Shares of Black Stone Minerals fell 2% to close at $12.95 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in BSM stock.</li>
</ul>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/06/46050117/wall-streets-most-accurate-analysts-give-their-take-on-3-tech-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Tech Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo via Shutterstock

Long Ideas

CETY

Top 2 Energy Stocks Which Could Rescue Your Portfolio This Quarter

Health Care

Press Releases

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist

Peraso Inc. (NASDAQ: PRSO): Revolutionizing Military Combat with Steerable Beam Technology see more stocks inside…

Rani Therapeutics to Participate in Upcoming Investor Conferences

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update

Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update

Comments

Rani Therapeutics Hldgs

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL